West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 316.59 USD -1.34% Market Closed
Market Cap: 22.9B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

West Pharmaceutical Services Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

West Pharmaceutical Services Inc
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
West Pharmaceutical Services Inc
NYSE:WST
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Cash Interest Paid
$383m
CAGR 3-Years
1%
CAGR 5-Years
25%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Cash Interest Paid
$79m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

West Pharmaceutical Services Inc
Glance View

Market Cap
23B USD
Industry
Life Sciences Tools & Services

West Pharmaceutical Services Inc. is a leading global manufacturer of advanced drug delivery systems and medical device components, catering primarily to the pharmaceutical and biotechnology sectors. Founded in 1923, the company has built a robust reputation for its innovative solutions that enhance the safety and efficacy of medications. With a focus on producing high-quality packaging and delivery systems, West’s product lineup includes prefillable syringes, stoppers, and highly specialized devices that contribute to the growing demand for biologics and complex medications. This focus on quality has positioned West as a trusted partner for major pharmaceutical companies, and its strategic global footprint allows it to meet the rising demands of health systems worldwide. As the healthcare landscape evolves, West Pharmaceutical Services stands to benefit from several key industry trends, including the increased emphasis on patient-centric therapies and the demand for reliable and efficient drug administration methods. Investors can find assurance in the company’s commitment to innovation, as it invests heavily in research and development to stay ahead of emerging trends and regulatory changes. Additionally, West’s consistent financial performance, with steady revenue growth and healthy profit margins, showcases its resilience and operational efficiency. As the biopharmaceutical market continues to expand, West’s strategic alignment with cutting-edge therapeutic developments positions it well for future growth, painting a promising picture for potential investors looking to tap into the burgeoning healthcare sector.

WST Intrinsic Value
214.31 USD
Overvaluation 32%
Intrinsic Value
Price

See Also

Back to Top